The former Financial Times (FT) broke out that Johnson & Johnson is about to acquire partner Pharmacyclics for more than $17 billion, and AbbVie announced that it will acquire Pharmacyclics for about $21 billion to strengthen its oncology drug pipeline. Aibowei said in the statement that the deal will consist of 58% of cash and 42% of AbbVie common stock. Pharmacyclics shareholders can choose cash, AbbVie stock or a combination of two. In the cash portion, Abbott will pay $261.25 per share, a 13% premium to Pharmacyclics' closing price on the Nasdaq stock market on Wednesday. AbbVie said it hopes to complete the acquisition through a combination of existing funds and new debt and stocks. Albert Web CEO Richard Gonzalez said in a statement that the breakthrough anticancer drug Imbruvica developed by Pharmacyclics is not only perfectly complementary to the company's oncology pipeline, but also has a strong clinical effect against a wide range of hematological malignancies. Currently, Imbruvica has been approved for use in four types of blood cancers in the United States and is approved for use in three types of blood cancers in Europe. Earlier this year, Pharmacyclics said that Imbruvica's sales in the US market this year is expected to reach $10 billion. Johnson & Johnson and Pharmacyclics signed a nearly $1 billion partnership in 2011 to develop Imbruvica (ibrutinib), a pioneered oral Bruton's tyrosine kinase (BTK) inhibitor that inhibits tumor cell replication and metastasis. Luton tyrosine kinase (BTK) acts as an anti-cancer. For a long period of time, large pharmaceutical companies have been more likely to sign a partnership with smaller pharmaceutical companies to facilitate the joint development of their products, rather than acquiring small companies as a whole. However, in recent years, with the increasing competition in the industry, this method has gradually been replaced by the form of “big fish eating small fish†or even “big fish eating big fishâ€. Electric Balance,Weighing Balance,High Stability Balance,Electric Precision Balance Guangdong Widinlsa International Co.Ltd , https://www.widinlsas.com